<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13g" xmlns:ns1="http://www.sec.gov/edgar/common">
  <schemaVersion>X0202</schemaVersion>
<headerData>
    <submissionType>SCHEDULE 13G/A</submissionType>
    <previousAccessionNumber>0001493152-25-007954</previousAccessionNumber>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0002055074</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <amendmentNo>2</amendmentNo>
      <securitiesClassTitle>American Depository Shares, each representing 4,000 Ordinary Shares, no par value</securitiesClassTitle>
      <eventDateRequiresFilingThisStatement>04/27/2026</eventDateRequiresFilingThisStatement>
      <issuerInfo>
        <issuerCik>0001611747</issuerCik>
        <issuerName>Scinai Immunotherapeutics Ltd.</issuerName>
        <issuerCusips>
          <issuerCusipNumber>09073Q203</issuerCusipNumber>
        </issuerCusips>
        <issuerPrincipalExecutiveOfficeAddress>
          <ns1:street1>JERUSALEM BIOPARK, 2ND FLOOR</ns1:street1>
          <ns1:street2>HADASSAH EIN KEREM CAMPUS</ns1:street2>
          <ns1:city>JERUSALEM</ns1:city>
          <ns1:stateOrCountry>L3</ns1:stateOrCountry>
          <ns1:zipCode>00000</ns1:zipCode>
        </issuerPrincipalExecutiveOfficeAddress>
      </issuerInfo>
      <designateRulesPursuantThisScheduleFiled>
        <designateRulePursuantThisScheduleFiled>Rule 13d-1(c)</designateRulePursuantThisScheduleFiled>
      </designateRulesPursuantThisScheduleFiled>
    </coverPageHeader>
    <coverPageHeaderReportingPersonDetails>


      <reportingPersonName>LCK JNK 1 LLC</reportingPersonName>
      <citizenshipOrOrganization>X1</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>317366</soleVotingPower>
        <sharedVotingPower>0</sharedVotingPower>
        <soleDispositivePower>317366</soleDispositivePower>
        <sharedDispositivePower>0</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>317366</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>6.33</classPercent>
      <typeOfReportingPerson>OO</typeOfReportingPerson>
    </coverPageHeaderReportingPersonDetails>
    <items>
      <item1>
        <issuerName>Scinai Immunotherapeutics Ltd.</issuerName>
        <issuerPrincipalExecutiveOfficeAddress>JERUSALEM BIOPARK, 2ND FLOOR, HADASSAH EIN KEREM CAMPUS, JERUSALEM, ISRAEL
00000</issuerPrincipalExecutiveOfficeAddress>
      </item1>
      <item2>
        <filingPersonName>LCK JNK 1 LLC</filingPersonName>
        <principalBusinessOfficeOrResidenceAddress>3105 NW 107TH AVENUE
SUITE 103
DORAL, Florida
33172</principalBusinessOfficeOrResidenceAddress>
        <citizenship>LCK JNK 1 LLC - UNITED STATES</citizenship>
      </item2>
      <item3>
        <notApplicableFlag>Y</notApplicableFlag>
      </item3>
      <item4>
        <amountBeneficiallyOwned>317,366</amountBeneficiallyOwned>
        <classPercent>6.33</classPercent>
        <numberOfSharesPersonHas>
          <solePowerOrDirectToVote>LCK JNK 1 LLC - 317,366</solePowerOrDirectToVote>
          <sharedPowerOrDirectToVote>LCK JNK 1 LLC - 0</sharedPowerOrDirectToVote>
          <solePowerOrDirectToDispose>LCK JNK 1 LLC - 317,366</solePowerOrDirectToDispose>
          <sharedPowerOrDirectToDispose>LCK JNK 1 LLC - 0</sharedPowerOrDirectToDispose>
        </numberOfSharesPersonHas>
      </item4>
      <item5>
        <notApplicableFlag>Y</notApplicableFlag>
      </item5>
      <item6>
        <notApplicableFlag>Y</notApplicableFlag>
      </item6>
      <item7>
        <notApplicableFlag>Y</notApplicableFlag>
      </item7>
      <item8>
        <notApplicableFlag>Y</notApplicableFlag>
      </item8>
      <item9>
        <notApplicableFlag>Y</notApplicableFlag>
      </item9>
      <item10>
        <notApplicableFlag>N</notApplicableFlag>
        <certifications>By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.</certifications>
      </item10>
    </items>
    <signatureInformation>
      <reportingPersonName>LCK JNK 1 LLC</reportingPersonName>
      <signatureDetails>
        <signature>/s/ Richard J. Kertzman</signature>
        <title>Richard J. Kertzman, Sole Member</title>
        <date>06/18/2026</date>
      </signatureDetails>
    </signatureInformation>
  </formData>
</edgarSubmission>
